Literature DB >> 18210381

Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells.

Yadollah Omidi1, Jaleh Barar, Somaieh Ahmadian, Hamid Reza Heidari, Mark Gumbleton.   

Abstract

Brain trafficking of amino acids is mainly mediated by amino acids transport machineries of the blood-brain barrier (BBB), where astrocytes play a key maintenance role. However, little is known about astrocytes impacts on such transport systems, in particular system L that consists of large and small neutral amino acids (NAAs) transporters, that is, LAT1/4F2hc and LAT2/4F2hc, respectively. In the current investigation, functionality and expression of system L were studied in the immortalized mouse brain microvascular endothelial b.End3 cells cocultured with astrocytes or treated with astrocyte-conditioned media (ACM). LAT2/4F2hc mediated luminal uptake of L-phenylalanine and L-leucine resulted in significantly decreased affinity of system L in b.End3 cells treated with ACM, while LAT2/4F2hc mediated luminal uptake of L-alanine remained unchanged. Gene expression analysis revealed marked upregulation of LAT1 and 4F2hc, but downregulation of LAT2 in b.End3 cells cultured with ACM. The basal to apical transport of L-phenylalanine and L-alanine appeared to be significantly greater than that of the apical to basal direction in b.End3 cells indicating an efflux functionality of system L. No marked influence was observed for transport of L-phenylalanine in b.End3 cells cocultured with astrocytes, while a slight decrease was seen for L-alanine in the basal to apical direction. Based on our findings, we propose that system L functions as influx and/or efflux transport machinery displaying a greater propensity for the outward transport of large and small NAAs. Astrocytes appeared to modulate the transcriptic expression and uptake functionalities of system L, but not the transport activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18210381     DOI: 10.1002/cbf.1455

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  11 in total

1.  Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells.

Authors:  Xiaobin Zhang; Daria Y Alakhova; Elena V Batrakova; Shu Li; Zhihui Yang; Yili Li; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-08-02       Impact factor: 4.147

Review 2.  Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.

Authors:  David J Mc Carthy; Meenakshi Malhotra; Aoife M O'Mahony; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

3.  Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.

Authors:  Songhua Fan; Delong Meng; Tao Xu; Yuanyuan Chen; Jingkun Wang; Xiaoying Li; Hongyan Chen; Daru Lu; Juxiang Chen; Qing Lan
Journal:  Med Oncol       Date:  2013-02-14       Impact factor: 3.064

4.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

5.  Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.

Authors:  Yadollah Omidi; Jaleh Barar
Journal:  Bioimpacts       Date:  2012-02-02

Review 6.  Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?

Authors:  Robert Dantzer; Adam K Walker
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

7.  Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas.

Authors:  Zhen Haining; Nobuyuki Kawai; Keisuke Miyake; Masaki Okada; Shuichi Okubo; Xiang Zhang; Zhou Fei; Takashi Tamiya
Journal:  BMC Clin Pathol       Date:  2012-02-28

8.  Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis.

Authors:  Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Harold W de Valk; Anne M J Paans; Pieter J J Sauer; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2013-09-04       Impact factor: 4.123

9.  Ocular Drug Delivery; Impact of in vitro Cell Culture Models.

Authors:  Jaleh Barar; Masoud Asadi; Seyed Abdolreza Mortazavi-Tabatabaei; Yadollah Omidi
Journal:  J Ophthalmic Vis Res       Date:  2009-10

Review 10.  Advanced drug delivery and targeting technologies for the ocular diseases.

Authors:  Jaleh Barar; Ayuob Aghanejad; Marziyeh Fathi; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.